Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives

Duchenne muscular dystrophy (DMD) is a disease linked to the X-chromosome which affects 1 in 3,600-6,000 newborn males. It is manifested by the absence of the dystrophin protein in muscle fibres, which causes progressive damage leading to death in the third decade of life. The only medication so far...

Descripción completa

Detalles Bibliográficos
Autores principales: DE LOS ANGELES BEYTÍA, MARIA, VRY, JULIA, KIRSCHNER, JANBERND
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440798/
https://www.ncbi.nlm.nih.gov/pubmed/22655510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440798/
https://www.ncbi.nlm.nih.gov/pubmed/22655510

Ejemplares similares